Enorama Pharma AB (OSTO:ERMA) Book Value per Share: kr-0.49 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ERMA Enorama Pharma AB OSTO:ERMA
28 GF Score
Price kr0.31
GF Value kr0.41
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Enorama Pharma AB Book Value per Share?

Enorama Pharma AB OSTO:ERMA -3.14% 28 Book Value per Share is kr-0.49 as of Mar. 2026. GuruFocus rates OSTO:ERMA with a GF Score™ of 28/100 and a GF Value™ of kr0.41 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Enorama Pharma AB's book value per share for the quarter that ended in Mar. 2026 was kr-0.49.

During the past 12 months, Enorama Pharma AB's average Book Value Per Share Growth Rate was -418.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Enorama Pharma AB was 37.60% per year. The lowest was -61.40% per year. And the median was 6.00% per year.

Enorama Pharma AB's current price is kr0.308. Its book value per share for the quarter that ended in Mar. 2026 was kr-0.49. Hence, today's PB Ratio of Enorama Pharma AB is .

During the past 12 years, the highest P/B Ratio of Enorama Pharma AB was 396.34. The lowest was 1.05. And the median was 20.38.


Enorama Pharma AB  (OSTO:ERMA) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Enorama Pharma AB Book Value per Share Related Terms


Enorama Pharma AB Book Value per Share Historical Data

* Premium members only.

The historical data trend for Enorama Pharma AB's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enorama Pharma AB Book Value per Share Chart

Enorama Pharma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.25 2.72 0.39 0.13 -0.31

Enorama Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.12 -0.06 -0.31 -0.49

OSTO:ERMA vs ZTS, UTHR, VTRS: Book Value per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Enorama Pharma AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enorama Pharma AB PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enorama Pharma AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Enorama Pharma AB's PB Ratio falls into.


OSTO:ERMA
28GF Score
Enorama Pharma AB OSTO:ERMA
Book Value per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enorama Pharma AB Book Value per Share Calculation

Enorama Pharma AB's Book Value Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-23.45-0.00)/74.59
=-0.31

Enorama Pharma AB's Book Value Per Share for the quarter that ended in Mar. 2026 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-36.64-0.00)/74.59
=-0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of kr-0.49 mean?
Enorama Pharma AB (OSTO:ERMA) has a Book Value per Share of kr-0.49 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Enorama Pharma AB and its competitors.
Is Enorama Pharma AB's Book Value per Share too high?
Enorama Pharma AB's current Book Value per Share is kr-0.49. Overall, Enorama Pharma AB has a GF Score™ of 28/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Enorama Pharma AB's Book Value per Share compare to ZTS and UTHR?
Enorama Pharma AB's Book Value per Share of kr-0.49 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Enorama Pharma AB and its competitors. Enorama Pharma AB's current Book Value per Share is kr-0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enorama Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, Enorama Pharma AB (OSTO:ERMA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.41, compared to a current price of kr0.31 — trading 24.9% below its estimated fair value. The current Book Value per Share is kr-0.49. Enorama Pharma AB's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Enorama Pharma AB (OSTO:ERMA), the current Book Value per Share is kr-0.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enorama Pharma AB (OSTO:ERMA) Overvalued in 2026?

Based on GuruFocus' analysis, Enorama Pharma AB stock appears to be undervalued. The current stock price of kr0.31 is trading 24.9% below its estimated GF Value™ of kr0.41. GuruFocus considers Enorama Pharma AB to be Modestly Undervalued.

Key valuation signals for OSTO:ERMA:

  • Book Value per Share: kr-0.49
  • GF Value™: kr0.41 vs. price of kr0.31 (24.9% below fair value)
  • GF Score™: 28/100 with 4 warning signs

No single metric tells the full story. See the OSTO:ERMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Enorama Pharma AB Business Description

Address Vastra Varvsgatan 19, Malmo, SWE, SE-211 77
Enorama Pharma AB is a pharmaceutical company that focuses on consumer-friendly medicated chewing gum containing generic substances. It provides medicated gums containing generic pharmaceutical substances, developed through its ChewMed technology platform.
28GF Score

Get the complete analysis for OSTO:ERMA

Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.31
Price
kr0.41
GF Value